Dong-A Socio Holdings Co., Ltd. (000640.KS)
KRW 110000.0
(4.86%)
KRW 110000.0
(4.86%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 691.88 Billion KRW | 25.31% |
| 2022 | 552.13 Billion KRW | 2.71% |
| 2021 | 537.58 Billion KRW | 10.19% |
| 2020 | 487.88 Billion KRW | 4.14% |
| 2019 | 468.5 Billion KRW | 26.33% |
| 2018 | 370.87 Billion KRW | -6.93% |
| 2017 | 398.5 Billion KRW | 10.3% |
| 2016 | 361.29 Billion KRW | -15.93% |
| 2015 | 429.77 Billion KRW | 15.64% |
| 2014 | 371.63 Billion KRW | 25.89% |
| 2013 | 295.19 Billion KRW | -38.78% |
| 2012 | 482.2 Billion KRW | 64.4% |
| 2011 | 293.31 Billion KRW | 9.64% |
| 2010 | 267.53 Billion KRW | -3.89% |
| 2009 | 278.37 Billion KRW | 4.03% |
| 2008 | 267.59 Billion KRW | 17.73% |
| 2007 | 227.29 Billion KRW | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 735.81 Billion KRW | 5.63% |
| 2024 Q1 | 696.56 Billion KRW | 0.68% |
| 2023 FY | 691.88 Billion KRW | 25.31% |
| 2023 Q2 | 642.21 Billion KRW | -1.59% |
| 2023 Q1 | 652.57 Billion KRW | 18.19% |
| 2023 Q3 | 675.19 Billion KRW | 5.13% |
| 2023 Q4 | 691.88 Billion KRW | 2.47% |
| 2022 Q4 | 552.13 Billion KRW | 1.01% |
| 2022 FY | 552.13 Billion KRW | 2.71% |
| 2022 Q3 | 546.6 Billion KRW | 1.91% |
| 2022 Q2 | 536.38 Billion KRW | -0.42% |
| 2022 Q1 | 538.65 Billion KRW | 0.2% |
| 2021 Q4 | 537.58 Billion KRW | 0.38% |
| 2021 FY | 537.58 Billion KRW | 10.19% |
| 2021 Q3 | 535.52 Billion KRW | 4.84% |
| 2021 Q2 | 510.8 Billion KRW | 3.52% |
| 2021 Q1 | 493.41 Billion KRW | 1.13% |
| 2020 Q3 | 478.86 Billion KRW | -0.68% |
| 2020 Q1 | 455.39 Billion KRW | -2.8% |
| 2020 Q2 | 482.13 Billion KRW | 5.87% |
| 2020 Q4 | 487.88 Billion KRW | 1.88% |
| 2020 FY | 487.88 Billion KRW | 4.14% |
| 2019 Q3 | 383.57 Billion KRW | -5.27% |
| 2019 Q4 | 468.5 Billion KRW | 22.14% |
| 2019 Q2 | 404.93 Billion KRW | -1.02% |
| 2019 Q1 | 409.09 Billion KRW | 10.31% |
| 2019 FY | 468.5 Billion KRW | 26.33% |
| 2018 Q4 | 370.87 Billion KRW | 0.95% |
| 2018 FY | 370.87 Billion KRW | -6.93% |
| 2018 Q2 | 381.37 Billion KRW | -2.31% |
| 2018 Q1 | 390.37 Billion KRW | -2.04% |
| 2018 Q3 | 367.39 Billion KRW | -3.67% |
| 2017 Q4 | 398.5 Billion KRW | -0.29% |
| 2017 Q3 | 399.67 Billion KRW | -6.86% |
| 2017 Q2 | 429.1 Billion KRW | -5.18% |
| 2017 FY | 398.5 Billion KRW | 10.3% |
| 2017 Q1 | 452.55 Billion KRW | 25.26% |
| 2016 FY | 361.29 Billion KRW | -15.93% |
| 2016 Q2 | 375.43 Billion KRW | -12.82% |
| 2016 Q3 | 369.06 Billion KRW | -1.69% |
| 2016 Q4 | 361.29 Billion KRW | -2.11% |
| 2016 Q1 | 430.62 Billion KRW | 0.2% |
| 2015 Q4 | 429.77 Billion KRW | 5.22% |
| 2015 Q3 | 408.43 Billion KRW | -3.78% |
| 2015 FY | 429.77 Billion KRW | 15.64% |
| 2015 Q1 | 404.51 Billion KRW | 8.85% |
| 2015 Q2 | 424.46 Billion KRW | 4.93% |
| 2014 Q3 | 356.79 Billion KRW | 5.56% |
| 2014 FY | 371.63 Billion KRW | 25.89% |
| 2014 Q4 | 371.63 Billion KRW | 4.16% |
| 2014 Q2 | 337.99 Billion KRW | 10.58% |
| 2014 Q1 | 305.66 Billion KRW | 3.55% |
| 2013 Q2 | 228.09 Billion KRW | 20.66% |
| 2013 Q3 | 274.79 Billion KRW | 20.47% |
| 2013 FY | 295.19 Billion KRW | -38.78% |
| 2013 Q4 | 295.19 Billion KRW | 7.43% |
| 2013 Q1 | 189.04 Billion KRW | -60.8% |
| 2012 Q1 | 276.94 Billion KRW | 0.0% |
| 2012 Q4 | 482.2 Billion KRW | 0.0% |
| 2012 FY | 482.2 Billion KRW | 64.4% |
| 2011 Q2 | 240.35 Billion KRW | -1.98% |
| 2011 FY | 293.31 Billion KRW | 9.64% |
| 2011 Q1 | 245.2 Billion KRW | 0.0% |
| 2011 Q3 | 240.27 Billion KRW | -0.03% |
| 2010 Q3 | 239.1 Billion KRW | -10.51% |
| 2010 Q1 | 253.11 Billion KRW | 0.0% |
| 2010 Q2 | 267.17 Billion KRW | 5.56% |
| 2010 FY | 267.53 Billion KRW | -3.89% |
| 2009 Q1 | 269.18 Billion KRW | 0.0% |
| 2009 Q2 | 262.34 Billion KRW | -2.54% |
| 2009 FY | 278.37 Billion KRW | 4.03% |
| 2009 Q3 | 262.75 Billion KRW | 0.15% |
| 2008 Q3 | 223.63 Billion KRW | 6.17% |
| 2008 Q1 | 205.67 Billion KRW | 0.0% |
| 2008 Q2 | 210.63 Billion KRW | 2.41% |
| 2008 FY | 267.59 Billion KRW | 17.73% |
| 2007 Q1 | 165.12 Billion KRW | 0.0% |
| 2007 Q2 | 172.64 Billion KRW | 4.55% |
| 2007 Q3 | 231.46 Billion KRW | 34.07% |
| 2007 FY | 227.29 Billion KRW | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Yuyu Pharma, Inc. | 39.4 Billion KRW | -1655.726% |
| Ildong Holdings Co., Ltd. | 382.06 Billion KRW | -81.092% |
| HANDOK Inc. | 300.01 Billion KRW | -130.619% |
| Kukje Pharma Co., Ltd. | 30.66 Billion KRW | -2156.473% |
| Yuhan Corporation | 230.07 Billion KRW | -200.725% |
| Dong-A ST Co., Ltd. | 406.7 Billion KRW | -70.119% |
| SAMSUNG PHARM. Co., LTD. | 595.48 Million KRW | -116087.784% |
| Hanmi Pharm. Co., Ltd. | 572.86 Billion KRW | -20.775% |
| Hanall Biopharma Co.,Ltd | 1.29 Billion KRW | -53512.226% |
| Ilyang Pharmaceutical Co.,Ltd | 85.15 Billion KRW | -712.451% |
| Dong Sung Bio Pharm.Co.,Ltd. | 43.27 Billion KRW | -1498.883% |
| MYUNGMOON Pharm co.,Ltd | 90.48 Billion KRW | -664.661% |
| Hana Pharm Co., Ltd. | 26.53 Billion KRW | -2507.621% |
| Yuyu Pharma, Inc. | 39.4 Billion KRW | -1655.726% |
| Ilsung Pharmaceuticals Co., Ltd. | 238.12 Million KRW | -290452.776% |
| REYON Pharmaceutical Co., Ltd. | 225.05 Billion KRW | -207.43% |
| Aprogen pharmaceuticals,Inc. | 180.99 Billion KRW | -282.261% |
| JW Holdings Corporation | 554.58 Billion KRW | -24.756% |
| Ildong Pharmaceutical Co., Ltd. | 217.84 Billion KRW | -217.608% |
| Chong Kun Dang Pharmaceutical Corp. | 219.76 Billion KRW | -214.83% |
| JW Pharmaceutical Corporation | 170.28 Billion KRW | -306.319% |
| Shin Poong Pharm.Co.,Ltd. | 46.15 Billion KRW | -1399.155% |
| Hyundai Pharmaceutical Co., Ltd. | 39.2 Billion KRW | -1664.783% |
| Samil Pharmaceutical Co.,Ltd | 175.87 Billion KRW | -293.385% |
| Jeil Pharmaceutical Co.,Ltd | 84.96 Billion KRW | -714.308% |
| Yuyu Pharma, Inc. | 39.4 Billion KRW | -1655.726% |
| Kwang Dong Pharmaceutical Co., Ltd. | 235.64 Billion KRW | -193.616% |
| Daewoong pharmaceutical Co.,Ltd | 469.68 Billion KRW | -47.307% |
| JW Pharmaceutical Corporation | 170.28 Billion KRW | -306.319% |
| Yuhan Corporation | 230.07 Billion KRW | -200.725% |
| Jeil Pharma Holdings Inc | 173.03 Billion KRW | -299.861% |
| Yungjin Pharm. Co., Ltd. | 66.88 Billion KRW | -934.48% |
| Suheung Co., Ltd. | 467.85 Billion KRW | -47.883% |
| JW Pharmaceutical Corporation | 170.28 Billion KRW | -306.319% |
| Samjin Pharmaceuticals Co., Ltd. | 118.63 Billion KRW | -483.186% |
| Korea United Pharm Inc. | 40.33 Billion KRW | -1615.167% |
| CKD Bio Corp. | 146.92 Billion KRW | -370.903% |
| Daewon Pharmaceutical Co., Ltd. | 146.04 Billion KRW | -373.73% |
| Dongwha Pharm.Co.,Ltd | 48.25 Billion KRW | -1333.792% |
| Whan In Pharm Co.,Ltd. | 632.02 Million KRW | -109370.531% |
| Shin Poong Pharm.Co.,Ltd. | 46.15 Billion KRW | -1399.155% |
| Chong Kun Dang Holdings Corp. | 468.03 Billion KRW | -47.827% |
| Boryung Corporation | 204.21 Billion KRW | -238.799% |
| Bukwang Pharmaceutical Co., Ltd. | 79.38 Billion KRW | -771.531% |
| Ilyang Pharmaceutical Co.,Ltd | 85.15 Billion KRW | -712.451% |
| JW Lifescience Corporation | 46.31 Billion KRW | -1393.931% |